Literature DB >> 31026411

Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity.

Eric M Brown1,2, Douglas J Kenny1,2, Ramnik J Xavier1,2,3.   

Abstract

The intestinal microbiota plays a crucial role in influencing the development of host immunity, and in turn the immune system also acts to regulate the microbiota through intestinal barrier maintenance and immune exclusion. Normally, these interactions are homeostatic, tightly controlled, and organized by both innate and adaptive immune responses. However, a combination of environmental exposures and genetic defects can result in a break in tolerance and intestinal homeostasis. The outcomes of these interactions at the mucosal interface have broad, systemic effects on host immunity and the development of chronic inflammatory or autoimmune disease. The underlying mechanisms and pathways the microbiota can utilize to regulate these diseases are just starting to emerge. Here, we discuss the recent evidence in this area describing the impact of microbiota-immune interactions during inflammation and autoimmunity, with a focus on barrier function and CD4+ T cell regulation.

Entities:  

Keywords:  CD4 T cells; autoimmunity; barrier function; cytokine secretion; inflammation; inflammatory bowel disease; microbial metabolites; microbial mimicry; microbiota; tolerance; type 1 diabetes

Mesh:

Year:  2019        PMID: 31026411     DOI: 10.1146/annurev-immunol-042718-041841

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  70 in total

Review 1.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

2.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

3.  News Feature: Editing the microbiome.

Authors:  Jyoti Madhusoodanan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

4.  Capsulized faecal microbiota transplantation ameliorates post-weaning diarrhoea by modulating the gut microbiota in piglets.

Authors:  Wenjie Tang; Daiwen Chen; Bing Yu; Jun He; Zhiqing Huang; Ping Zheng; Xiangbing Mao; Yuheng Luo; Junqiu Luo; Quyuan Wang; Huifen Wang; Jie Yu
Journal:  Vet Res       Date:  2020-04-16       Impact factor: 3.683

5.  Changes in the gut microbiota: a possible factor influencing peripheral blood immune indexes in non-obese diabetic mice.

Authors:  Yiling Wu; Qi You; Jingjin Fei; Jie Wu
Journal:  Antonie Van Leeuwenhoek       Date:  2021-08-09       Impact factor: 2.271

6.  Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.

Authors:  Pu Xiaoyu; Ge Chao; Dong Lihua; Chang Pengyu
Journal:  Gut Microbes       Date:  2020-03-27

Review 7.  Microbial modulation of intestinal T helper cell responses and implications for disease and therapy.

Authors:  Markus B Geuking; Regula Burkhard
Journal:  Mucosal Immunol       Date:  2020-08-13       Impact factor: 7.313

Review 8.  Heterogeneity in the initiation, development and function of type 2 immunity.

Authors:  William C Gause; Carla Rothlin; P'ng Loke
Journal:  Nat Rev Immunol       Date:  2020-05-04       Impact factor: 53.106

Review 9.  Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.

Authors:  Junfeng Zou; Chen Liu; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

10.  Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD).

Authors:  S Battella; S Oliva; L Franchitti; R La Scaleia; A Soriani; S Isoldi; C Capuano; C Pighi; S Morrone; R Galandrini; A Santoni; G Palmieri
Journal:  Mucosal Immunol       Date:  2019-10-03       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.